questionText: To ask the Secretary of State for Health and Social Care, how the full roll-out of the non-specific symptom pathways is being measured; and how their development has included the less survivable cancers.
answerText: Since 2019, NHS England and cancer alliances have been developing non-specific symptom (NSS) pathways for patients who present with vague and non-site-specific symptoms which do not clearly align to a tumour type. Full roll out of NSS pathways has been ac...
heading: Rare Cancers: Diagnosis